Philip Alan Gregory
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Tumour metastasis is the major cause of cancer related death in solid tumours such as the breast and prostate. My laboratory conducts research into understanding how tumour cells gain aggressive properties and spread throughout the body. We focus on identifying the importance of the molecular changes that occur as cells transition to aggressive forms, specifically on RNA changes involving microRNAs and alternative splicing (including circular RNAs).
-
Characterising an RNA splicing pathway driving prostate cancer metastasis and therapy resistance, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
-
Use of a new molecule (miR-342) to discover important pathways to treat advanced breast cancer, NBCF - Investigator Initiated Research Scheme, 01/01/2018 - 01/07/2021
-
Characterising novel alternative splicing networks that promote tumour cell plasticity, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
-
Targeting microRNA-driven mesenchymal to epithelial transition to suppress prostate cancer metastasis, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
-
Role of the microRNA target Quaking in alternative splicing during EMT and cancer progression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
Connect With Me
Available For Media Comment.